Therapeutic candidates are molecules or entities that early research suggests might be developed into treatments for disease. They emerge from screening and optimisation stages before rigorous preclinical and clinical testing. Understanding this term helps readers interpret claims about “identifying candidates” as a preliminary step, not evidence that a safe and effective medicine already exists, which is crucial for realistic expectations around AI‑enabled discovery.